Leveraging Clinical Opportunities For Success

The frequency of drug manufacturer coupon utilization is associated with more market competition—but not patients’ out-of-pocket costs.

From the Pharmacy of the Year winner announcement to a powerful Women in Pharmacy Workshop, here's what you missed on day 2 of ThoughtSpot.

The World Health Organization (WHO) shared their enthusiasm for the “appropriate” use of new technologies, and urged safety and caution as automation becomes normalized in the health care sphere.

The Drug Topics® team is on the ground at ThoughtSpot 2022. Here's what you missed on Day 1.

The newly FDA-approved prescription product delivers nalmefene to the nasal cavity to reverse the effects of opioid overdose.

According to commentaries published in the Annals of Internal Medicine, doctors remain split on the question.